Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...
B&T is Australia’s leading news publication magazine for the advertising, marketing, media and PR industries. B&T is owned by parent company The Misfits Media Company Pty Ltd.